Do caffeine and more selective adenosine A_2A receptor antagonists protect against dopaminergic neurodegeneration in Parkinson's disease?

Parkinsonism & related disorders2020Chen JF, Schwarzschild MA

Study designReview

SubjectHuman & animal

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

AdenosineAdenosine A2 Receptor AntagonistsAnimalsCaffeineDisease Models, AnimalHumansNeuroprotective AgentsParkinson DiseaseReceptor, Adenosine A2A

DOI 10.1016/j.parkreldis.2020.10.024

PMID 33349580